chloramphenicol has been researched along with radezolid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeVito, J; Duffy, EM; Franceschi, F; Ippolito, JA; Lawrence, L; McConnell, TS; Skripkin, E; Sutcliffe, J | 1 |
| G C, K; Hilgers, M; José Picazo, J; Locke, JB; Morales, G; Rahawi, S; Shaw, KJ; Stein, JL | 1 |
| Makarov, GI; Reshetnikova, RV | 1 |
| Crowe-McAuliffe, C; Wilson, DN | 1 |
4 other study(ies) available for chloramphenicol and radezolid
| Article | Year |
|---|---|
R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistance.
Topics: Acetamides; Anti-Bacterial Agents; Binding Sites; Binding, Competitive; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Protein Biosynthesis; Ribosomes; RNA, Bacterial; RNA, Ribosomal, 23S; Staphylococcus aureus | 2008 |
Elevated linezolid resistance in clinical cfr-positive Staphylococcus aureus isolates is associated with co-occurring mutations in ribosomal protein L3.
Topics: Acetamides; Anti-Infective Agents; Bacterial Proteins; Drug Resistance, Bacterial; Linezolid; Methyltransferases; Microbial Sensitivity Tests; Mutation; Oxazolidinones; Ribosomal Protein L3; Ribosomal Proteins; Staphylococcus aureus | 2010 |
Investigation of radezolid interaction with non-canonical chloramphenicol binding site by molecular dynamics simulations.
Topics: Anti-Bacterial Agents; Binding Sites; Chloramphenicol; Escherichia coli; Molecular Dynamics Simulation; Oxazolidinones | 2021 |
Putting the antibiotics chloramphenicol and linezolid into context.
Topics: Anti-Bacterial Agents; Bacteria; Chloramphenicol; Drug Development; Drug Resistance, Bacterial; Humans; Linezolid; Models, Molecular; Oxazolidinones; Protein Biosynthesis; Protein Synthesis Inhibitors; Ribosomes; Structure-Activity Relationship | 2022 |